StockNews.com Initiates Coverage on Milestone Scientific (NYSE:MLSS)

StockNews.com began coverage on shares of Milestone Scientific (NYSE:MLSS) in a research report issued to clients and investors on Thursday. The brokerage set a “hold” rating on the stock.

Milestone Scientific Trading Up 3.2 %

MLSS opened at $0.64 on Thursday. The company has a market cap of $49.02 million, a P/E ratio of -6.40 and a beta of 0.97. The business’s 50-day moving average price is $0.65 and its 200-day moving average price is $0.69. Milestone Scientific has a 12 month low of $0.52 and a 12 month high of $1.35.

Milestone Scientific (NYSE:MLSS) last released its quarterly earnings data on Friday, March 29th. The company reported ($0.03) EPS for the quarter. The company had revenue of $2.26 million during the quarter. Milestone Scientific had a negative return on equity of 86.72% and a negative net margin of 70.50%.

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in Milestone Scientific stock. AE Wealth Management LLC purchased a new stake in shares of Milestone Scientific Inc. (NYSE:MLSS) during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 27,936 shares of the company’s stock, valued at approximately $26,000. 5.79% of the stock is owned by institutional investors and hedge funds.

About Milestone Scientific

Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.